Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Metolazone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,915Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Micro Labs`s Generics Metolazone Receives Approval in US
    Micro Labs`s Generics Metolazone Receives Approval in US

    06 Nov 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217563

    FDA
    06 Nov 2024
    Share Share
    Leading's Metolazone Receives Approval In the US
    Leading's Metolazone Receives Approval In the US

    17 Apr 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218606

    FDA
    17 Apr 2024
    Share Share
    AACE's Generic Metolazone Receives Approval in the U.S.
    AACE's Generic Metolazone Receives Approval in the U.S.

    25 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216216

    FDA
    25 Oct 2022
    Share Share
    Eskayef's Generic Metolazone Receives Approval in the U.S.
    Eskayef's Generic Metolazone Receives Approval in the U.S.

    24 Oct 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215616

    FDA
    24 Oct 2022
    Share Share
    Bayshore Pharmaceuticals Announces Commercial Launch of ANDA Approved Products
    Bayshore Pharmaceuticals Announces Commercial Launch of ANDA Approved Products

    15 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211115005109/en

    BUSINESSWIRE
    15 Nov 2021
    Share Share
    Rubicon's Generic Metolazone Receives Approval In the US
    Rubicon's Generic Metolazone Receives Approval In the US

    20 Aug 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215184

    FDA
    20 Aug 2021
    Share Share